Impact of community pharmacist antibiotic prescribing for minor ailments: an interrupted time series analysis
Leung V, Langford B, Brown KA, Ghahramani D, Hoang J, Oberai A, Tadrous M, Daneman N, Saqib K, Schwartz K. BMJ Open. 2025; 15(11): e107109.
Publications
Initiation of opioid agonist treatment following hospital-treated opioid toxicities and the risk of repeat events in Ontario, Canada: a cohort study using inverse probability of treatment weights
Ledlie S, Tadrous M, Bayoumi AM, McCormack D, Kent JT, Besharah J, Munro C, Gomes T. BMJ Public Health. 2025; 3(2): e002779.
Systemic therapies for psoriatic disease and serious adverse events in older adults: a population-based cohort study
Drucker AM, Sutradhar R, Ling V, Eder L, Gomes T, Fralick M, Iskandar RJ, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M. J Invest Dermatol. 2025; S0022-202X(25)03528-6. Epub 2025 Nov 15.
Patient and prescriber characteristics associated with return to daily-dispense methadone: a multilevel cohort study
Garg R, Ledlie S, McCormack D, Bozinoff N, Wyman J, Sproule B, Leece P, Tadrous M, Smoke A, Munro C, Gomes T. PLOS Ment Health. 2025; 2(11): e0000442.
Impact of direct oral anticoagulant uptake on hospitalizations for stroke/transient ischemic attack, intracranial hemorrhage, and gastrointestinal bleeding in individuals with atrial fibrillation: a population-based study
Antoniou T, McCormack D, Wang T, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2025; 39(6):e70051.
Evaluating regional and temporal variations in quality indicators for opioid initiation and pharmacist medication reviews in Ontario: a population-based repeated cross-sectional study
Torabi A, Chu C, Abdul Aziz Y, Yada N, Chaudhry S, Wang T, Gomes T, Tadrous M. Can Pharm J (Ott). 2025; 17151635251358873. Epub 2025 Aug 22.
The impact of the COVID-19 pandemic on homecare use for individuals with physical disabilities stratified by sex, age, and mental health condition: a cohort study using administrative health data
Senthinathan A, Tadrous M, Hussain S, McKay S, Moineddin R, Chu C, Jaglal SB, Shepherd J, Cadel L, Noonan VK, Craven BC, Tu K, Guilcher SJT. Home Health Care Manag Pract. Epub 2025 Aug 18.
Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary
Hamzat B, Wang T, Garg R, Iacono A, Tadrous M, Wu F, Wyman J, Dodd Z, Pinkerton S, Smoke A, Gomes T. Int J Drug Policy. 2025; 143:104918. Epub 2025 Jul 10.
Changing trends in safer opioid supply uptake, dose and hydromorphone volume in Ontario: a population-based cross-sectional study
Xu F, Wang T, Kolla G, Campbell T, Watts T, Ledlie S, Koncz D, Tadrous M, Gomes T. Int J Drug Policy. 2025; 143:104905. Epub 2025 Jun 28.
The rise and fall of raloxifene use for osteoporosis, 1999-2022
Shogry FF, Hayes KN, Kim S, Burden AM, Tadrous M, Aggarwal S, Cadarette SM. Osteoporos Int. 2025; Jun 11 [Epub ahead of prin]t.